Why is Astec Lifescienc falling/rising?

As of 31-Jul, Astec Lifesciences Ltd is experiencing a price increase, currently trading at 905.60, which reflects a rise of 43.9 or 5.09%. Today's performance indicates that the stock has outperformed its sector by 6.12%, reaching an intraday high of Rs 918, a 6.53% increase. However, despite this short-term gain, the stock has shown a negative trend over the past month, with a decline of 6.54%, and a significant drop of 25.16% over the last year. The company has been facing challenges, including operating losses and a high Debt to EBITDA ratio of 2.64 times, which indicates a weak long-term fundamental strength. Additionally, the stock has consistently underperformed against benchmarks, with negative results reported for the last five consecutive quarters.
In the broader market context, while the Sensex has declined by 1.22% over the past week, Astec Lifesciences has managed to post a modest gain, suggesting some resilience in the short term. However, the company's year-to-date performance shows a decline of 9.89%, contrasting sharply with the Sensex's increase of 3.90%. This underperformance is compounded by a significant drop in investor participation, with delivery volume falling by 76.29% against the five-day average, indicating a lack of confidence among investors. Overall, while the stock's recent price increase may reflect short-term trading activity, the underlying fundamentals and long-term performance metrics suggest ongoing challenges for Astec Lifesciences Ltd.